108 research outputs found
Synthesis of 2âČ,3âČ-Dideoxynucleoside Phosphoesters Using H-Phosphonate Chemistry on Soluble Polymer Support
International audiencePhosphorylation of ddC and 3TC was efficiently performed on soluble poly(ethylene glycol) support. The corresponding 5âČ-monophosphate derivatives were obtained by oxidation of the support bound 5âČ-H-phosphonate intermediates. Then, di- and triphosphorylations were carried out using a carbonyldiimidazole activation step followed by nucleophilic substitution with suitable phosphate salts. Trivalent phosphorus chemistry appeared as a good alternative for monophosphate synthesis of acid-sensitive 2âČ,3âČ-dideoxynucleosides
Insights into the Soluble PEG-Supported Synthesis of Cytosine-Containing Nucleoside 5âČ-Mono-, Di-, and Triphosphates
International audienceNucleoside phosphoesters (nucleotides) have crucial roles in a large variety of biological processes including nucleic acid biosynthesis and their corresponding analogues are extensively used as biological tools. Herein, we describe a new and efficient synthetic procedure involving polyethylene glycol (PEG) as soluble support and regioselective mono-, di-, and triphosphorylation steps. Applied to natural and synthetic cytosine containing nucleosides, this methodology allowed the preparation of various phosphorylated forms in high yields and good purity
Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues
International audienceMalaria still affects around 200 million people and is responsible for more than 400,000 deaths per year, mostly children in subequatorial areas. This disease is caused by parasites of the Plasmodium genus. Only a few WHO-recommended treatments are available to prevent or cure plasmodial infections, but genetic mutations in the causal parasites have led to onset of resistance against all commercial antimalarial drugs. New drugs and targets are being investigated to cope with this emerging problem, including enzymes belonging to the main metabolic pathways, while nucleoside and nucleotide analogues are also a promising class of potential drugs. This review highlights the main metabolic pathways targeted for the development of potential antiplasmodial therapies based on nucleos(t)ide analogues, as well as the different series of purine-containing nucleoside and nucleotide derivatives designed to inhibit Plasmodium falciparum purine metabolism.
Structural Insights into the Inhibition of Cytosolic 5âČ-Nucleotidase II (cN-II) by Ribonucleoside 5âČ-Monophosphate Analogues
Cytosolic 5âČ-nucleotidase II (cN-II) regulates the intracellular nucleotide pools within the cell by catalyzing the dephosphorylation of 6-hydroxypurine nucleoside 5âČ-monophosphates. Beside this physiological function, high level of cN-II expression is correlated with abnormal patient outcome when treated with cytotoxic nucleoside analogues. To identify its specific role in the resistance phenomenon observed during cancer therapy, we screened a particular class of chemical compounds, namely ribonucleoside phosphonates to predict them as potential cN-II inhibitors. These compounds incorporate a chemically and enzymatically stable phosphorus-carbon linkage instead of a regular phosphoester bond. Amongst them, six compounds were predicted as better ligands than the natural substrate of cN-II, inosine 5âČ-monophosphate (IMP). The study of purine and pyrimidine containing analogues and the introduction of chemical modifications within the phosphonate chain has allowed us to define general rules governing the theoretical affinity of such ligands. The binding strength of these compounds was scrutinized in silico and explained by an impressive number of van der Waals contacts, highlighting the decisive role of three cN-II residues that are Phe 157, His 209 and Tyr 210. Docking predictions were confirmed by experimental measurements of the nucleotidase activity in the presence of the three best available phosphonate analogues. These compounds were shown to induce a total inhibition of the cN-II activity at 2 mM. Altogether, this study emphasizes the importance of the non-hydrolysable phosphonate bond in the design of new competitive cN-II inhibitors and the crucial hydrophobic stacking promoted by three protein residues
New Series of Acyclic Nucleoside Phosphonates as Potent Antimalarials
International audienc
New Series of Acyclic Nucleoside Phosphonates as Potent Antimalarials
International audienc
SynthÚse et étude d'inhibiteurs potentiels de la 5'-nucléotidase cytosolique II (Analogues de mononucléotides en série phosphonate et leurs prodrogues)
Les analogues de nuclĂ©osides reprĂ©sentent une famille d'agents thĂ©rapeutiques trĂšs largement utilisĂ©e en chimiothĂ©rapie anticancĂ©reuse. Cependant, des phĂ©nomĂšnes de rĂ©sistance d'origine multifactorielle apparaissent et il semble que la surexpression d'une enzyme, la 5'-nuclĂ©otidase cytosolique II (cN-II) soit un des facteurs impliquĂ©s. Nous nous sommes donc intĂ©ressĂ©s Ă son Ă©tude ainsi qu'Ă la synthĂšse d'inhibiteurs potentiels de type analogues de nuclĂ©osides phosphonates modifiĂ©s en position ĂĄ/Ăą. Ce manuscrit rapporte dans un premier temps aux particularitĂ©s de la cN-II puis l'Ă©laboration d'un test d'Ă©valuation efficace. Suite Ă la mise en oeuvre de diffĂ©rentes techniques d'enzymologie, le dosage colorimĂ©trique au vert de Malachite a Ă©tĂ© retenu. Le second chapitre dĂ©crit l'optimisation et la synthĂšse d'analogues de type alcyne phosphonate selon deux approches puis l'Ă©valuation de leur capacitĂ© Ă inhiber la cN-II. La troisiĂšme partie traite d'une nouvelle approche synthĂ©tique de nuclĂ©osides phosphonates Ăą-modifiĂ©s via l'utilisation d'un intermĂ©diaire Ăą-cĂ©tophosphonate. Des dĂ©rivĂ©s de type Ăą-hydroxyphosphonate et Ăą-oximephosphonate ont Ă©tĂ© obtenus et testĂ©s. Enfin, la mise au point d'une stratĂ©gie inĂ©dite pour la synthĂšse de prodrogues bisSATE de Ăą-hydroxyphosphonates (tĂȘtes de sĂ©rie) via l'ouverture d'un Ă©poxyde par un phosphite a Ă©tĂ© rĂ©alisĂ©eNucleosidic analogs are widely used as therapeutic agents in antitumoral chemotherapy. However, cellular resistance appears in a multifactorial manner and it seems that overexpression of an enzyme, the 5'-cytosolic nucleotidase (cN-II) may be involved in this phenomenon. We were interested in the study of this enzyme in order to design and synthesize potential inhibitors belonging to the family of nucleoside analogs in the ĂĄ/Ăą-modified phosphonate series. First, we reviewed literature data on the nucleotidase family and particularly on cN-II, then we engaged in the setting up of an evaluation test using various enzymological techniques. Thus, green malachite colorimetric assay was successful and efficient for the evaluation of the inhibitor capacity of our different derivatives. Secondly, we described the optimisation and the synthesis of alkynylphosphonate nucleoside analogs using two different pathways. These latter were tested and the cytosine analog inhibited 65% of the enzyme activity. Then, a new synthetic approach to Ăą-modified nucleoside phosphonates was reported using a Ăą-ketophosphonate as key intermediate. Ăą-hydroxyphosphonate et Ăą-oximephosphonate analogs were obtained and inhibited 50% of the enzyme activity. Finally, a novel prodrug stategy for the synthesis of bisSATE ester of Ăą-hydroxyphosphonates (our leading series) was designed and developpedMONTPELLIER-BU Sciences (341722106) / SudocSudocFranceF
Nouveaux anti-viraux pour le traitement des affections associées aux virus émergents
Dans un premier chapitre, nous avons prĂ©sentĂ© un historique succinct de la chimiothĂ©rapie antivirale et l'utilisation d'analogues nuclĂ©os(t)idiques. Nous nous sommes focalisĂ©s en particulier sur les nuclĂ©osides phosphonates acycliques (ANP) en tant qu'antiviraux potentiels. Dans un second chapitre, nous avons dĂ©crit la synthĂšse de b-cĂ©to, b-hydroxylamino et b-O-(benzyl)hydroxylamino ANP dĂ©rivĂ©s de l'adĂ©nine et de la cytosine. Les isomĂšrs (R) et (S)-b-hydroxy-ANP ont Ă©tĂ© prĂ©parĂ©s par dĂ©doublement du racĂ©mique correspondant avec le (S)-MPA et l'attribution des configurations absolues a Ă©tĂ© effectuĂ©e par RMN et calculs de modĂ©lisation molĂ©culaire. Nous avons aussi dĂ©veloppĂ© une mĂ©thodologie de synthĂšse de b-azido-ANP, ces derniers Ă©tant utilisĂ©s pour la prĂ©paration de b-amino-ANP par hydrogĂ©nation catalytique. Dans un troisiĂšme chapitre, nous avons prĂ©sentĂ© la synthĂšse des 2H-azirine et cis-aziridne-ANP et examinĂ© lÊč ouverture de cycle comme voie d'accĂšs Ă des ANP a,b-fonctionnalisĂ©s. Les propriĂ©tĂ©s biologiques de ces nouveaux ANP ont Ă©tĂ© Ă©valuĂ©es en culture cellulaire sur un certain nombre de virus Ă ADN et ARN.In the first chapter, we presented a brief history of antiviral chemotherapy and use of nucleos(t)ide analogues, especially acyclic nucleoside phosphonates as potential antiviral agents. In the chapter-II we have successfully synthesized Ă-keto, Ă-hydroxylamino and Ă-O-(benzyl)hydroxylamino ANPs of adenine and cytosine derivatives. Then (R) and (S)- Ă-hydroxy-ANPs were prepared via chiral resolution of racemic Ă-hydroxy-ANPs with (S)-MPA and assignment of absolute configuration was achieved using NMR and molecular modeling studies. We also developed a methodology for the synthesis of Ă-azido-ANPs and those were used for the preparation of Ă-amino-ANPs by catalytic hydrogenation. In third chapter, we synthesized 2H-azirine and cis-aziridine-ANPs and explored their ring opening to functionalized Ă, Ă-ANPs. The novel ANPs obtained during this study were evaluated for their inhibitory effect on a number of DNA and RNA viruses in cell culture experiments.MONTPELLIER-BU Sciences (341722106) / SudocSudocFranceF
Synthesis of N-methylene phosphonate aziridines: Reaction scope and mechanistic insights
International audienceA series of N-carbamoyl aziridines has been treated by diethyl phosphite in presence of n-BuLi to afford α-methylene phosphonate aziridines in modest yields. The study of the reaction's scopes and the analysis of byproducts indicated that this transformation proceeds via a unique mechanism. The mechanism that produces the α-methylene phosphonate relies in the use of BuLi, where both the lithium ion and then the presence of the nucleophilic butyl is essential. In addition, the nature of the final compound, either α-methylene phosphonate or α-methylene-gem-bisphosphonate derivatives containing an aziridine motif, is highly dependent on the nature of the base used
- âŠ